ImmunityBio and Microsoft create 3D model to support Covid-19 research
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create...
Read More...
Focus:
-
![Exscientia Covid-19]()
Exscientia forms UK-US partnership to screen possible Covid-19 drugs
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with...
Read More...
-
![Noveome ST266 Covid-19]()
Noveome studies anti-inflammatory drug ST266 in Covid-19
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential...
Read More...
-
![emergent biosolutions manufacturing]()
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and...
Read More...
-
![]()
US overtakes China with largest number of coronavirus cases
The US now has more confirmed cases of novel coronavirus (Covid-19) than any other country with 85,996 cases, surpassing China…
Read More…
-
![]()
UK pledges £210m to CEPI for Covid-19 vaccine development
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government...
Read More...
-
![Novavax Nanoflu influenza]()
Novavax’s Nanoflu compares well to Fluzone Quadrivalent
US-based Novavax has published top-line Phase III data for its seasonal influenza vaccine Nanoflu in...
Read More...
-
![eco-wish list pharma]()
Turning pharma green: an eco-wish list for the industry
The reality of climate change is hard to ignore. As one of the biggest polluters,...
Read More...
-
![Novartis data Zolgensma]()
Novartis publishes more positive data for Zolgensma
Novartis subsidiary AveXis presented positive, updated data from three clinical trials of its one-dose gene...
Read More...
-
![Covid-19 task force]()
Stanford’s StartX joins Covid-19 response with task force
Stanford University non-profit start-up StartX has launched StartX Med Covid-19 task force to mobilise 70...
Read More...
Close
Close
Close
Go Top